Grants and Contributions:
Title:
Business Innovation – Increasing Lead Generation and In Vitro Diagnostic Test Product Sales Revenues in the United States and Canada.
Agreement Number:
1008768
Agreement Value:
$250,125.00
Agreement Date:
Jul 1, 2023 - Jun 30, 2024
Description:
Business Innovation – Increasing Lead Generation and In Vitro Diagnostic Test Product Sales Revenues in the United States and Canada.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6P2
Reference Number:
172-2023-2024-Q2-1008768
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
121519920
Recipient Type:
For-profit organization
Recipient's Operating Name:
Response Biomedical
Recipient's Legal Name:
Response Biomedical Corp.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512